The Clinical Services and Standards Committee of the British Society of Gastroenterology has undertaken to work with colleagues to prepare guidelines on the management of various gastrointestinal disorders in order to improve the standard of practice of clinical gastroenterology in specified areas. The following is intended as a guide to aid in the preparation of these guidelines.
BSG Proposal for Guidelines – Submission Template
AGREE Instrument II_ (Appraisal of Guidelines for Research and Evaluation)
BSG Guidelines Writing and Review Process Document (March 2023)
Dr Rupert Ransford, BSG Guidelines Lead/ Guidelines Editor Gut says: “we are delighted to announce that the British Society of Gastroenterology has successfully renewed the accreditation by NICE to follow detailed BSG processes in order to produce high quality clinical guidelines. This renewed accreditation is now valid for 5 years until 2023 and continues from the original accreditation which was achieved in 2013. The BSG can continue to use the highly coveted NICE Accreditation Mark and looks forward to producing independent, evidence-based guidance on the most effective ways to prevent, diagnose and treat disease and ill health in Gastroenterology and Hepatology”. Professor Emad M El-Omar, Editor in Chief at GUT says “Gut is very proud to publish the BSG Guidelines, which are of the highest international calibre. These Guidelines are respected and followed the world over and have certainly contributed to the success of our journal.”
These Guidelines and guidance documents have been prepared or endorsed by the British Society of Gastroenterology. They represent a consensus of best practice based on the available evidence at the time of preparation. They may not apply in all situations and should be interpreted in the light of specific clinical situations and resource availability. Clinical decisions involve a complex analysis of the patient’s condition and available routes of action which may lead a clinician to take a course of action that varies from these guidelines or guidance. Guidelines and guidance documents are not rules and should not be interpreted as establishing a legal standard of care.British Society of Gastroenterology guidelines aim to improve the standard of practice of clinical gastroenterology and hepatology and represent a consensus of best practice based on the available evidence. Accreditation of the process we use to produce best practice clinical guideline through the NICE Accreditation Programme demonstrates that our guidelines are of a very high quality. We are confident that NICE accreditation will heighten the standing of our guidelines and will lead to further improvement in the quality of patient care.
These BSG guidelines represent a consensus of best practice based on the available evidence at the time of preparation. They may not apply in all situations and should be interpreted in the light of specific clinical situations and resource availability. Further controlled clinical studies may be needed to clarify aspects of these statements, and revision may be necessary as new data appear. Clinical consideration may justify a course of action at variance to these recommendations, but we suggest that reasons for this are documented in the medical record. BSG guidelines are intended to be an educational device to provide information that may assist in providing care to patients. They are not rules and should not be construed as establishing a legal standard of care or as encouraging, advocating, requiring, or discouraging any particular treatment.
First published on 13 Oct 2023
Over 2.5 million gastrointestinal endoscopic procedures are carried out in the United Kingdom (UK) every year. Procedures are carried out with local anaesthetic r with sedation. Sedation is commonly used for gastrointestinal endoscopy, but the type and amount of sedation […]
First published on 29 Sep 2023
These guidelines for the diagnosis and management of cholangiocarcinoma (CCA) were commissioned by the British Society of Gastroenterology liver section. The guideline writing committee included a multidisciplinary team of experts from various specialties involved in the management of CCA, as […]
First published on 26 Jul 2023
These ESGE Guidelines have been reviewed by the Endoscopy Section and replace the BSG Guideline on Complications of Gastrointestinal Endoscopy (2006).
First published on 01 Mar 2023
Summary Genomic medicine enables the identification of patients with rare or ultra-rare monogenic forms of inflammatory bowel disease (IBD) and supports clinical decision making. Patients with monogenic IBD frequently experience extremely early onset of treatment-refractory disease, with complex extraintestinal disease […]
First published on 17 Oct 2022
GI endoscopy is highly resource-intensive with a significant contribution to greenhouse gas (GHG) emissions and waste generation. Sustainable endoscopy in the context of climate change is now the focus of mainstream discussions between endoscopy providers, units and professional societies. In […]
First published on 11 Jul 2022
Functional dyspepsia (FD) is a common disorder of gut–brain interaction, affecting approximately 7% of individuals in the community, with most patients managed in primary care. The last British Society of Gastroenterology (BSG) guideline for the management of dyspepsia was published […]
First published on 31 May 2022
Authors (Guideline development group (GDG)) Kevin J Monahan / Michael M. Davies (Co-chairs, and lead authors). Co-authors: Muti Abulafi, Ayan Banerjea, Brian Nicholson, Ramesh Arasaradnam, Neil Barker, Sally Benton, Richard Booth, David Burling, Rachel Carten, Nigel D’Souza, James East, Jos […]
First published on 27 May 2022
Background Eosinophilic oesophagitis (EoE) is an increasingly common cause of dysphagia in both children and adults, as well as one of the most prevalent oesophageal diseases with a significant impact on physical health and quality of life. We have provided […]
First published on 22 Feb 2022
Abstract Background Lynch syndrome is the most common genetic predisposition for hereditary cancer but remains underdiagnosed. Large prospective observational studies have recently increased understanding of the effectiveness of colonoscopic surveillance and the heterogeneity of cancer risk between genotypes. The need […]
First published on 29 Sep 2021
Iron deficiency anaemia (IDA) is a major cause of morbidity and burden of disease worldwide. It can generally be diagnosed by blood testing and remedied by iron replacement therapy (IRT) using the oral or intravenous route. The many causes […]